Multi-medicine scheme optimization method and system
The drug effect index is calculated through structured functional test data, and the drug dosage and frequency of medication are dynamically adjusted, which solves the problem of low efficiency and difficulty in formulating conventional multi-drug plans, and achieves efficient optimization and improvement of multi-drug plans.
Patent Information
- Application Number
- CN202410984373.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-22
- Publication Date
- 2024-12-06
AI Technical Summary
The formulation of conventional multi-drug plans is inefficient and difficult, and the sensitivity and resistance of patients to drugs vary with the duration of taking the drug, resulting in frequent adjustments, which increases the difficulty of formulation.
By obtaining structured functional test data collected by wearable devices, calculating the efficacy index, optimizing the drug dosage and medication frequency, dynamically adjusting the medication plan, and using multi-drug optimization models to predict the best medication plan.
The efficient and accurate optimization of multi-drug regimens has been achieved, reducing the efficiency and difficulty of formulation, avoiding side effects of drugs, and improving the efficacy.
Smart Images

Figure CN119092039A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the field of precision medicine technology, and in particular to a multi-drug regimen optimization method and system. Background Art
[0002] Research has found that there is a linear growth relationship between the number of conventional prescription drugs used and the patient's age. Especially for elderly patients, they may need to take more than five types of medicine at a time. Different drugs have different mechanisms of action. If they are not distributed properly, they may cause serious side effects and harm the patient's health.
[0003] Conventional multi-drug regimens are formulated by doctors based on clinical experience, which requires doctors to have relatively rich medical experience, resulting in low efficiency and difficulty in formulating multi-drug regimens. In addition, patients' sensitivity and resistance to drugs may change with the length of time they take the medication. Therefore, multi-drug regimens need to be adjusted regularly, further making the formulation of multi-drug regimens inefficient and difficult.
[0004] The above contents are only used to assist in understanding the technical solution of the present application and do not constitute an admission that the above contents are prior art. Summary of the invention
[0005] The main purpose of this application is to provide a multi-drug regimen optimization method, device, equipment and storage medium thereof, aiming to solve the technical problems of low efficiency and high difficulty in formulating conventional multi-drug regimens.
[0006] To achieve the above-mentioned purpose, the present application provides a multi-drug regimen optimization method, which is applied to a multi-drug regimen optimization system, and the multi-drug regimen optimization system includes: a wearable device, and the method includes:
[0007] Acquiring test data of a structured functional test of a subject before and after multiple medications collected by a wearable device, wherein the structured functional test is used to reflect the subject's goal-oriented motor function;
[0008] Determining the drug efficacy index of the subject to the drug taken according to the test data, wherein the drug efficacy index is used to indicate the sensitivity and / or tolerance of the subject to the drug taken;
[0009] According to the dosage and pharmacodynamic index corresponding to each drug taken by the subject, a medication regimen for the subject to achieve a preset efficacy level is determined, wherein the medication regimen includes: the dosage, medication interval and medication frequency corresponding to each drug taken by the subject at a single time.
[0010] Optionally, the drug taken by the subject is a mixed drug prepared by dividing multiple drugs for single administration in a drug prescription and remixing them according to different doses.
[0011] Optionally, the drug taken by the subject is a mixed drug prepared by cutting multiple drugs for a single dose in a drug prescription into small portions by a laser cutting device and remixing them according to different doses, wherein the mixed drug is a tablet or a capsule.
[0012] Optionally, the multi-drug regimen optimization system includes: a user terminal, and the step of obtaining test data of a structured functional test of a subject before and after taking multiple medications collected by a wearable device includes:
[0013] Control the user terminal to send a preset test instruction and a preset brain stimulation signal to the subject, so that the subject moves in response to the test instruction and the brain stimulation signal, and obtains the test data collected by the wearable device, wherein the brain stimulation signal is used to stimulate the subject's brain network.
[0014] Optionally, the multi-drug regimen optimization system comprises: a user terminal, and the test items of the structured functional test comprise: an alternating speed walking test;
[0015] The test content of the alternating speed walking test includes: after the subject sets the wearable device at the knee joint, the subject performs alternating speed walking in response to the first test instruction output by the user terminal, and the first test instruction includes: start walking instruction, fast walking instruction, slow walking instruction, turn instruction and stop walking instruction;
[0016] The wearable device collects walking data of the subject in response to each of the first test instructions, and the walking data includes: walking step length, walking time and walking speed.
[0017] Optionally, the multi-drug regimen optimization system includes: a user terminal, and the test items of the structured functional test include: an arm swing symmetry test;
[0018] The test content of the arm swing symmetry test includes: after the subject sets the wearable device at the elbow joint, the subject performs an arm swing movement in response to a second test instruction output by the user terminal, and the second test instruction includes: a start swing instruction, a fast swing instruction, a slow swing instruction, and a stop swing instruction;
[0019] The wearable device collects the swing data of the subject in response to each of the second test instructions, and the swing data includes: swing amplitude, swing duration and swing speed.
[0020] Optionally, the multi-drug regimen optimization system includes: a user terminal, and the test items of the structured functional test include: a cross-stepping test;
[0021] The test content of the cross-stepping test includes: after the subject sets the wearable device at the knee joint, the subject performs a cross-stepping movement in response to a third test instruction output by the user terminal, and the third test instruction includes: an instruction for the first foot to move in a first horizontal direction, an instruction for the second foot to move in a second horizontal direction, and an instruction for the first foot to move in a third horizontal direction;
[0022] The wearable device collects cross-stepping data of the subject in response to each of the third test instructions, and the cross-stepping data includes: cross-stepping step length, cross-stepping duration and cross-stepping speed.
[0023] Optionally, the multi-drug regimen optimization system comprises: a user terminal, and the test items of the structured functional test comprise: a dual-task test of marking time in place;
[0024] The test content of the dual-task stepping test includes: after the subject sets the wearable device at the knee joint, the subject performs single-task and dual-task stepping movements in response to the fourth test instruction output by the user terminal, and the fourth test instruction includes: a start stepping instruction and / or a question-and-answer instruction;
[0025] The wearable device collects the in-place stepping data of the subject in response to each of the fourth test instructions, and the in-place stepping data includes: in-place stepping amplitude, in-place stepping duration and in-place stepping speed.
[0026] Optionally, the multi-drug regimen optimization system comprises: a user terminal, and the test items of the structured functional test comprise: a lower limb joint movement symmetry test;
[0027] The test content of the lower limb joint movement symmetry test includes: after the subject sets the wearable device at the knee joint, the subject performs lower limb joint movements of the damaged lower limb and the undamaged lower limb respectively in response to the fifth test instruction output by the user terminal, and the fifth test instruction includes: a leg lifting instruction and a hand-touching ankle joint instruction of the lifted leg;
[0028] The wearable device collects lower limb joint data of the subject in response to each of the fifth test instructions, and the lower limb joint data includes: joint movement amplitude, joint movement duration and joint movement speed.
[0029] Optionally, the test data includes: test data before taking the medicine and test data after taking the medicine, and the step of determining the drug efficacy index of the subject to the taken medicine according to the test data includes:
[0030] According to a preset physical strength scoring standard, the pre-drug test data and the post-drug test data are scored respectively to obtain the pre-drug physical strength score and the post-drug physical strength score of the subject;
[0031] Determining the physical strength score difference between the physical strength score before taking the medication and the physical strength score after taking the medication;
[0032] The drug efficacy index corresponding to each of the drugs taken by the subject is determined according to the physical strength score difference and the dosage corresponding to each of the drugs taken by the subject.
[0033] Optionally, the step of determining the medication regimen for the subject to achieve a preset efficacy level according to the dosage and pharmacodynamic index corresponding to each of the drugs taken by the subject comprises:
[0034] The dosage and pharmacodynamic index corresponding to each drug taken by the subject are used as input data, and are input into a preset multi-drug regimen optimization model for prediction to obtain the medication regimen, wherein the multi-drug regimen optimization model is used to predict the therapeutic effect of each drug on the user and the brain damage area corresponding to the therapeutic effect based on the different dosages of each drug.
[0035] Optionally, the input data also includes: clinical diagnosis data, brain injury degree data and daily activity plan data of the subject.
[0036] The present application also provides a multi-drug regimen optimization system, the multi-drug regimen optimization system comprising: a wearable device, a user terminal, and a control terminal that are communicatively connected to each other;
[0037] The wearable device is used to collect test data of structured functional tests of subjects before and after multiple medications;
[0038] The user terminal is used to send a preset test instruction and a preset brain stimulation signal to the subject;
[0039] The control terminal is used to obtain test data of a structured functional test of a subject before and after taking multiple medications collected by a wearable device, wherein the structured functional test is used to reflect the subject's goal-oriented motor function; determine the subject's pharmacodynamic index to the medication taken based on the test data, wherein the pharmacodynamic index is used to indicate the subject's sensitivity and / or tolerance to the medication taken; determine a medication regimen for the subject to achieve a preset efficacy level based on the dose and pharmacodynamic index corresponding to each medication taken by the subject, wherein the medication regimen includes: the dose, medication interval, and medication frequency corresponding to each medication taken by the subject at a single time.
[0040] The present application discloses a multi-drug regimen optimization method, which obtains test data of a structured functional test of a subject before and after multiple medications collected by a wearable device, wherein the structured functional test is used to reflect the subject's goal-oriented motor function; then, based on the test data, the pharmacodynamic index of the subject to the medication taken is determined, wherein the pharmacodynamic index is used to indicate the subject's sensitivity and / or tolerance to the medication taken; then, based on the doses and pharmacodynamic indexes corresponding to the medications taken by the subject, a medication regimen for the subject to achieve a preset efficacy level is determined, wherein the medication regimen includes: the doses, medication intervals, and medication frequencies corresponding to each medication taken by the subject at a single time, so as to achieve efficient and high-precision optimization of the subject's multi-drug regimen. The test data obtained from the structured functional test can reflect the subject's physical vitality level after taking the medicine, as well as the subject's sensitivity and / or tolerance to the medicine taken; then, according to the corresponding dosage and pharmacodynamic index of each drug taken by the subject, the medication regimen for the subject to achieve the preset efficacy level is determined, so as to minimize the dosage within the appropriate efficacy range, screen out the optimal dosage of each drug, as well as the interval and frequency of taking, and obtain an optimized medication regimen. Since the sensitivity and resistance of the drug taker to the drug may change with the duration of medication; therefore, this method can continuously adjust and optimize the medication regimen based on the doctor's prescription for medication, through the dynamically obtained physiological changes of the drug taker to the drug taken, greatly reducing the efficiency and difficulty of formulating a multi-drug regimen. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 A schematic diagram of a multi-drug regimen optimization method according to an embodiment of the present application;
[0042] Figure 2 This is a schematic diagram of the mixed drug preparation process involved in the embodiment of the present application;
[0043] Figure 3 A schematic diagram of a user interface involved in an embodiment of the present application;
[0044] Figure 4 This is a schematic diagram of the structured functional test data collection results involved in the embodiment of the present application;
[0045] Figure 5 A schematic diagram of a scene of a dual-task test of stepping in place according to an embodiment of the present application;
[0046] Figure 6 A schematic diagram of the structure of a wearable device according to an embodiment of the present application;
[0047] Figure 7Schematic diagram of a multi-drug regimen optimization system according to an embodiment of the present application.
[0048] The realization of the purpose, functional features and advantages of this application will be further explained in conjunction with embodiments and with reference to the accompanying drawings. DETAILED DESCRIPTION
[0049] It should be understood that the specific embodiments described herein are only used to explain the present application and are not used to limit the present application.
[0050] In addition, the descriptions of "first", "second", etc. in this application are only for descriptive purposes and cannot be understood as indicating or implying their relative importance or implicitly indicating the number of technical features indicated. Therefore, the features defined as "first" and "second" may explicitly or implicitly include at least one of the features. In addition, "and / or" in the full text includes three solutions. Taking A and / or B as an example, it includes technical solution A, technical solution B, and technical solution that satisfies both A and B; in addition, the technical solutions between the various embodiments can be combined with each other, but it must be based on the ability of ordinary technicians in this field to implement. When the combination of technical solutions is contradictory or cannot be implemented, it should be deemed that such combination of technical solutions does not exist and is not within the scope of protection required by this application.
[0051] Research has found that there is a linear growth relationship between the number of conventional prescription drugs used and the patient's age. Especially for elderly patients, they may need to take more than five types of medicine at a time. In addition, patients may need to distribute the medicines themselves according to different drug ratios (for example, 1 / 2, 1 / 4 of a pill, etc.), making the medication process cumbersome.
[0052] An important part of specifying a medication regimen is to determine the relationship between drug dose (concentration) and drug toxicity; however, it may not be appropriate to simply control the drug dose to a level below the toxicity standard. According to clinical studies, when the total dose of each course of treatment remains unchanged, the use of different medication regimens (such as the number of medications, etc.) may produce large differences in efficacy. In addition, the bioavailability in the brain and the pharmacodynamics of the drug (i.e., the concentration and effect of the marker drug in the brain) will change. Even if the patient does not have significant toxic side effects at the time, drug overdose may occur during or after medication. Therefore, it is necessary to regularly optimize and adjust the multi-drug regimen used by patients with chronic diseases, which makes the formulation of multi-drug regimens inefficient and difficult.
[0053] In view of this, the present application provides a multi-drug regimen optimization method, which obtains the test data of the structured functional test of the subjects before and after taking multiple medications collected by the wearable device, and obtains the drug efficacy index based on the data to reflect the physical vitality level of the subjects after taking the drugs, as well as the sensitivity and / or tolerance of the subjects to the drugs taken; and then takes the obtained drug efficacy index as input, and predicts the efficacy of different doses of drugs on the subjects through the multi-drug optimization model, and determines the medication regimen for the subjects to achieve the preset efficacy level according to the doses and drug efficacy indexes corresponding to the drugs taken by the subjects, thereby screening out the optimal dosage of each drug and the interval and frequency of taking, and outputting the optimized medication regimen. Since the sensitivity and resistance of the drug taker to the drug may change with the duration of medication; therefore, this method can be used on the basis of the doctor's prescription for medication, and the medication regimen can be continuously adjusted and optimized by dynamically obtaining the physiological changes of the drug taker to the drugs taken, which greatly reduces the efficiency and difficulty of formulating the multi-drug regimen.
[0054] Reference Figure 1 , Figure 1 This is a flow chart of the first embodiment of the multi-drug regimen optimization method of the present application.
[0055] In this embodiment, the execution subject of the multi-drug regimen optimization method can be an electronic device, which can be a control terminal in the multi-drug regimen optimization system, such as a computer, a mobile phone, a tablet, etc. It can also be a network device, which is not limited in this embodiment. For the convenience of description, the following description of each embodiment is omitted. In this embodiment, the multi-drug regimen optimization method is applied to the multi-drug regimen optimization system, and the multi-drug regimen optimization system includes: a wearable device, and the method includes:
[0056] Step S10, obtaining test data of a structured functional test of the subject before and after taking the medicine multiple times collected by the wearable device, wherein the structured functional test is used to reflect the subject's goal-oriented motor function;
[0057] It should be understood that the multi-drug regimen in this embodiment refers to a medication regimen that requires taking two or more drugs at a time. The subject refers to an object that takes medication, undergoes structured functional testing, and collects data. Structured functional testing refers to exercising according to specific instructions to reflect the subject's goal-oriented motor function. The subject may be a patient with limb motor dysfunction caused by cerebrovascular disease, Parkinson's disease, etc.
[0058] When optimizing a multi-drug regimen, a doctor may first prescribe a prescription based on the subject's physical condition, i.e., the initial multi-drug regimen; and then let the subject wear a wearable device to perform a structured functional test before and after taking multiple doses of medication. Then, the test data of the subject's structured functional test collected by the wearable device is obtained.
[0059] In a feasible embodiment, the drug taken by the subject is a mixed drug prepared by dividing multiple drugs for single-dose administration in a drug prescription and remixing them according to different doses.
[0060] Since a multi-drug regimen contains multiple drugs, the subjects need to divide and take them according to different drug ratios (for example, 1 / 2, 1 / 4 of a pill, etc.), which makes the medication process very cumbersome. Therefore, based on the drug types and doses in the prescriptions issued by the doctor according to the subject's physical condition, each drug can be divided and remixed to obtain mixed drugs of different doses for the subject to take, thereby greatly simplifying the medication process for the subject.
[0061] Optionally, multiple drugs for single-dose in a prescription are cut into small portions by a laser cutting device, and remixed into a mixed drug according to different doses, wherein the mixed drug can be in the form of tablets or capsules.
[0062] For example, refer to Figure 2 , the subject is a Parkinson's disease patient, and the prescription issued by the doctor contains three drugs, including: dopamine prodrug, dopamine receptor agonist and enzyme inhibitor that degrades dopamine precursor. The subject needs to take the above three drugs six times a day in different proportions. Then, according to the proportion in the prescription, the above three drugs are divided and mixed in different doses to obtain capsule-type mixed drugs with different drug efficacy strengths (drug ratios) to facilitate oral administration by the subject. Furthermore, different colors can be given to mixed drugs with different drug efficacy strengths, for example, Figure 2 In the example, the yellow, green, blue and red colors are used to distinguish drugs for the subjects. Furthermore, the multi-drug regimen optimization system also includes a user terminal, which can be an APP in a smart terminal (e.g., a mobile phone) and can display a preset user interface to the subjects; Figure 3 , the user interface displays an optimized medication regimen, wherein the medication regimen includes medication dosage, medication interval, and medication frequency for different types of daily activities (e.g., indoor activities, outdoor activities, social activities, etc.). The drugs taken by the subjects are mixed drugs with different drug efficacy strengths prepared according to the optimized medication regimen, and different colors are used to distinguish the drug efficacy strengths of each mixed drug; the user can know how to use the drug by checking the color displayed in the medication regimen of the user interface; for example, if red is displayed, the user takes a red capsule, thereby greatly improving the convenience of medication for patients taking multiple drugs.
[0063] Step S20, determining the drug efficacy index of the subject to the drug taken according to the test data, wherein the drug efficacy index is used to indicate the sensitivity and / or tolerance of the subject to the drug taken;
[0064] Wearable devices can collect test data of structured functional tests performed on subjects before and after taking medication, namely, pre-medication data and post-medication data; by comparing the data differences between pre-medication data and post-medication data, the pharmacodynamic index corresponding to each of the various drugs taken by the subjects can be determined, and the pharmacodynamic index can indicate the subject's sensitivity and / or tolerance to the drugs taken.
[0065] Step S30, determining a medication regimen for the subject to achieve a preset efficacy level based on the dosage and pharmacodynamic index of each drug taken by the subject, wherein the medication regimen includes: the dosage, medication interval and medication frequency of each drug taken by the subject at a single time.
[0066] The dosage and pharmacodynamic index corresponding to each drug taken by the subject are important indicators to measure the therapeutic effects of different doses of drugs on the subjects; the dosage and pharmacodynamic index corresponding to each drug taken by the subject can be fed back to the doctor, for example, the data of the dosage and pharmacodynamic index corresponding to each drug taken by the subject can be transmitted to the user terminal used by the doctor, and the doctor can formulate a medication plan based on experience, and then transmit the medication plan to the user terminal used by the subject.
[0067] In a feasible implementation, the dose corresponding to each drug taken by the subject and the pharmacodynamic index corresponding to each drug can be used as input data; the input data is input into a preset multi-drug optimization model for prediction; the multi-drug optimization model can simulate the brain bioavailability of the subject at different doses of each drug, the brain damage area that may produce a therapeutic effect, and the achievable degree of treatment (efficacy) based on the input data, so as to predict the drug dose, medication frequency and interval that can achieve stable drug concentration in the subject, and finally output the optimized medication regimen for the subject to achieve a preset efficacy level, wherein the predicted medication regimen includes: the dose, medication interval and medication frequency corresponding to each drug taken by the subject in a single dose.
[0068] The multi-drug optimization model can include: pharmacodynamic model, which describes the absorption, distribution, metabolism and excretion process of the drug in the body (pharmacodynamics), and how these processes affect the biological effect of the drug (pharmacodynamics). By combining the subject's specific physiological parameters (such as weight, age, gender, etc.) and drug characteristics (such as dose, pharmacodynamic index, etc.), the efficacy of the drug at different doses can be predicted.
[0069] The optimized medication regimen can avoid overdose, minimize drug side effects, and maximize the efficacy of the treatment for the subjects.
[0070] In a feasible implementation manner, the input data further includes: clinical diagnosis data, brain injury degree data and daily activity plan data of the subject.
[0071] In this embodiment, the multi-drug optimization scheme can combine the subject's clinical diagnosis data, brain injury degree data, and daily activity plan data to generate a suitable medication plan for the subject. The daily activity plan is the functional activities that the subject engages in at home or outdoors, as well as social activities that require communication with others.
[0072] In one feasible implementation, the multi-drug regimen optimization model is used to predict the therapeutic effect of each drug on the user and the brain damage area corresponding to the therapeutic effect based on the different dosages of each drug.
[0073] Optionally, the multi-drug optimization model can determine the decay time constant of each drug based on the decay pharmacodynamics of various drug classes.
[0074] Optionally, the multi-drug optimization model can draw a pharmacodynamic index curve for each drug based on the pharmacodynamic index, and determine a medication regimen based on a preset efficacy level of the subject; wherein the prediction can be repeated regularly every day or every week to obtain an optimized medication regimen.
[0075] In this embodiment, the test data of the structured functional test of the subjects before and after taking multiple medications collected by the wearable device is obtained, and the drug efficacy index is obtained based on the data to reflect the physical vitality level of the subjects after taking the medications, as well as the sensitivity and / or tolerance of the subjects to the medications taken; and then according to the dosage and drug efficacy index corresponding to each of the drugs taken by the subjects, the medication regimen for the subjects to achieve the preset efficacy level is determined, so as to screen out the optimal dosage, interval and frequency of each drug, and output the optimized medication regimen. Since the sensitivity and resistance of the drug taker to the drug may change with the duration of medication; therefore, this method can continuously adjust and optimize the medication regimen based on the doctor's prescription for medication, through the dynamically obtained physiological changes of the drug taker to the drugs taken, which greatly reduces the efficiency and difficulty of formulating multiple drug regimens.
[0076] Further, based on the above first embodiment, a second embodiment of the multi-drug regimen optimization method of the present application is proposed. In this embodiment, the multi-drug regimen optimization system includes: a user terminal, step S10, the step of obtaining the test data of the structured functional test of the subject before and after multiple medications collected by the wearable device includes:
[0077] Step S11, controlling the user terminal to send preset test instructions and preset brain stimulation signals to the subject, so that the subject moves in response to the test instructions and the brain stimulation signals, and obtains test data collected by the wearable device, wherein the brain stimulation signals are used to stimulate the subject's brain network.
[0078] The user terminal can be a device composed of a mobile device such as a mobile phone, computer, tablet, watch, etc. with corresponding functional modules added, or it can be an additional device for receiving the basic physical data of the subject, such as limb length, etc., and transmitting the received data to the control terminal.
[0079] Optionally, an APP installed in the user terminal is provided, the APP displays a user interface for receiving body data input by the user and transmitting the received data to the control terminal.
[0080] When conducting structured functional tests, since some subjects may have difficulty with limb function due to chronic diseases of the elderly, and the degree of brain cell decline in the elderly is more serious, if a specific brain network is not stimulated, the subject may find it difficult to complete the test content. Therefore, the user terminal is controlled to send a preset test instruction to the subject so that the subject performs the corresponding movement steps according to the instruction, and at the same time, the user terminal is controlled to send a brain stimulation signal to the subject that can stimulate the subject's brain network.
[0081] Optionally, the brain stimulation signal may be an audio segment.
[0082] Optionally, when collecting test data, the collected test data may be displayed in real time in the user terminal.
[0083] Optionally, the wearable device includes: a posture sensor; the posture sensor includes: a gyroscope and an accelerometer, and has noise filtering and drift correction functions.
[0084] Optionally, the relevant processing of the test data can be performed by the control terminal or by the user terminal; illustratively, the user terminal pre-processes the collected test data (for example, amplitude, step length, duration, etc.) to obtain processed data (for example, angular velocity of each joint), and then transmits the processed data to the control terminal.
[0085] In a feasible implementation, the test items of the structured functional test include at least one of: an alternating speed walking test, an arm swing symmetry test, a cross-stepping test, an in-place stepping dual-task test, and a lower limb joint movement symmetry test.
[0086] In one feasible implementation, the multi-drug regimen optimization system includes: a user terminal, and test items of the structured functional test include: an alternating speed walking test;
[0087] The test content of the alternating speed walking test includes: after the subject sets the wearable device at the knee joint, the subject performs alternating speed walking movement in response to the first test instruction output by the user terminal, and the first test instruction includes: start walking instruction, fast walking instruction, slow walking instruction, turn instruction and stop walking instruction;
[0088] The wearable device collects walking data of the subject in response to each first test instruction, and the walking data includes: walking step length, walking time and walking speed.
[0089] The wearable device can dynamically collect corresponding test data after each test instruction is issued, and mark the corresponding timestamp for the test data under each instruction. Then, through the collected data, the time required for the subject to complete the switching of different test instructions (walking speed switching) can be determined, and the subject's physical fitness score can be determined based on the switching time of the test instructions.
[0090] Optionally, the physical fitness score of the subject may be determined by testing at least one of the switching duration and switching speed of the instructions and the walking speed and walking step length of the subject.
[0091] In a feasible embodiment, during the alternating speed walking test, the subject sets the wearable device at the knee joint, and the user terminal continuously outputs the first test instruction, including: start walking instruction, fast walking instruction, slow walking instruction, turn instruction and stop walking instruction. The subject performs alternating speed walking movement according to the received first test instruction, and each instruction will trigger the sensor to capture data within a specified time length until the next instruction is issued; the wearable device dynamically collects corresponding test data after each test instruction is issued, such as step length, speed and walking time, and marks the test data under each instruction with a corresponding timestamp, and then determines the time required for the subject to complete the switching of different test instructions (walking speed switching) and the step length under each instruction through the collected data, and determines the subject's physical fitness score based on the collected data.
[0092] For example, refer to Figure 4 During an alternating speed walking test, the user terminal alternately and continuously outputs: slow walking instructions and fast walking instructions; the histogram below shows the walking speed of the subject under each instruction; it can be found that the walking speed of the subject under the fourth fast walking instruction is slower than the walking speed of the third slow walking instruction, that is, the subject obviously has certain physical problems. Through the multi-drug optimization system provided in this embodiment, the structured functional test data of the subject can be collected in real time to help users optimize multi-drug regimens.
[0093] In one feasible implementation, the multi-drug regimen optimization system includes: a user terminal, and test items of the structured functional test include: an arm swing symmetry test;
[0094] The test content of the arm swing symmetry test includes: after the subject sets the wearable device at the elbow joint, the subject performs an arm swing movement in response to the second test instruction output by the user terminal, and the second test instruction includes: a start swing instruction, a fast swing instruction, a slow swing instruction, and a stop swing instruction;
[0095] The wearable device collects the swing data of the subject in response to each second test instruction, and the swing data includes: swing amplitude, swing duration and swing speed.
[0096] Optionally, the subject's physical strength score can be determined by testing the switching duration and switching speed of the instructions, and at least one of the subject's arm swing speed, swing amplitude, and swing difference between the two arms.
[0097] In a feasible embodiment, during the arm swing symmetry test, the subject sets the wearable device at the elbow joint, and then the user terminal continuously outputs the second test instruction, including: a start swing instruction, a fast swing instruction, a slow swing instruction and a stop swing instruction. The subject performs arm swinging movement according to the received second test instruction, and each instruction will trigger the sensor to capture data within a specified time length until the next instruction is issued; the wearable device dynamically collects corresponding test data after each test instruction is issued, for example, the amplitude, speed and time of the arm swing, and marks the corresponding timestamp for the test data under each instruction, and then determines the angular distance and speed of each arm swing of the subject through the collected data, as well as the difference between the two arms; and then according to the degree of difference in distance and speed between the two arms during the test, the subject's physical strength score (i.e., the comprehensive score of arm motor function) can be determined.
[0098] In one feasible implementation, the multi-drug regimen optimization system includes: a user terminal, and test items of the structured functional test include: a cross-stepping test;
[0099] The test content of the cross-stepping test includes: after the subject sets the wearable device at the knee joint, the subject performs a cross-stepping movement in response to the third test instruction output by the user terminal, and the third test instruction includes: an instruction for the first foot to move in a first horizontal direction, an instruction for the second foot to move in a second horizontal direction, and an instruction for the first foot to move in a third horizontal direction;
[0100] The wearable device collects cross-stepping data of the subject in response to each third test instruction, and the cross-stepping data includes: cross-stepping step length, cross-stepping duration and cross-stepping speed.
[0101] Optionally, the first foot and the second foot are the left and right feet respectively; the first horizontal direction can be forward or backward, the third horizontal direction can also be forward or backward, and the first horizontal direction and the third horizontal direction are different; the second horizontal direction can be left or right, the same as the direction of the second foot; for example, if the second foot is the left foot, the second horizontal direction is left.
[0102] Exemplarily, the third test instruction includes: an instruction for moving the left foot forward, an instruction for moving the right foot rightward, and an instruction for moving the left foot backward.
[0103] Optionally, the subject's physical fitness score can be determined by testing the switching duration and switching speed of the instructions, and at least one of the subject's cross-stepping height, cross-stepping speed, and cross-stepping difference between both feet.
[0104] In a feasible embodiment, during the cross-stepping test, the subject sets the wearable device at the knee joint, and the third test instruction continuously output by the user terminal includes: an instruction for the first foot to move in a first horizontal direction, an instruction for the second foot to move in a second horizontal direction, and an instruction for the first foot to move in a third horizontal direction. The subject performs a cross-stepping movement according to the received third test instruction, wherein the first direction, the second direction, and the third direction are all different. For example, the third test instruction includes: an instruction for the left foot to move forward, an instruction for the right foot to move to the right, and an instruction for the left foot to move backward. Each instruction triggers the sensor to capture data within a specified time length until the next instruction is issued; after each test instruction is issued, the wearable device dynamically collects corresponding test data, such as step length, speed, and walking time, and marks the corresponding timestamp for the test data under each instruction, and then determines the time required for the subject to complete the switching of different test instructions through the collected data, and determines the subject's physical strength score based on the switching time of the test instruction.
[0105] In one feasible implementation, the multi-drug regimen optimization system includes: a user terminal, and test items of the structured functional test include: a dual-task test of marking time in place;
[0106] The test content of the dual-task stepping test includes: after the subject sets the wearable device at the knee joint, the subject performs single-task and dual-task stepping movements in response to the fourth test instruction output by the user terminal, and the fourth test instruction includes: a stepping start instruction and / or a question-and-answer instruction;
[0107] The wearable device collects the in-place stepping data of the subject in response to each fourth test instruction, and the in-place stepping data includes: in-place stepping amplitude, in-place stepping duration and in-place stepping speed.
[0108] Single-task stepping in place means that the subject only responds to the start stepping instruction in the fourth test instruction and performs stepping movements in place; dual-task stepping in place means that after responding to the start stepping instruction in the fourth test instruction, the subject further responds to the question-and-answer instruction while performing stepping movements in place; wherein the question-and-answer instruction can be recalling the name of an animal, a place name, reciting a text, etc., which is used to study the impact of simple cognitive functions on the subjects.
[0109] Optionally, the subject's physical fitness score can be determined by the switching duration and switching speed of the test instructions under single-task and / or dual-task, and at least one of the subject's stepping height and stepping speed.
[0110] For example, refer to Figure 5 , which is a schematic diagram of the scene of the dual-task test of stepping in place. The step height decreases significantly with age, and is accompanied by various diseases, and falls and falls often occur, which eventually lead to fractures, hospitalization and even death. The conventional step height test uses reflective markers attached to the lower limbs and combines with an infrared dynamic analyzer to achieve high-precision detection of the step height value. However, the present application can accurately collect the step height of the subject under the dual-task test of stepping in place through wearable sensors; and compare the collected test data with the data obtained by the infrared dynamic analyzer, and find that the two have a significant correlation, with a correlation coefficient of approximately r = 0.93 (p <0.002), and the accuracy of the collection of step height data is relatively high. Through the dual-task test of stepping in place, the gait is quantified using dynamic parameters, which can better identify Parkinson's patients who have difficulty walking normally and have a higher risk of falling.
[0111] In a feasible embodiment, during the dual-task test of stepping in place, the subject sets the wearable device at the knee joint, and then the fourth test instruction continuously output by the user terminal includes: a start stepping instruction and / or a question-and-answer instruction; for example, the user terminal outputs a start stepping instruction, and then outputs a question-and-answer instruction, requiring the subject to recall the name of an animal, a place, or recite a text while stepping. Each instruction triggers the sensor to capture data within a specified time length until the next instruction is issued; after each test instruction is issued, the wearable device dynamically collects corresponding test data, such as step length, speed, and walking time, and marks the corresponding timestamp for the test data under each instruction, and then determines the angular distance, speed, step height, etc. of the subject under single-task and dual-task conditions through the collected data, and further determines the subject's physical strength score.
[0112] In one feasible implementation, the multi-drug regimen optimization system includes: a user terminal, and test items of the structured functional test include: a lower limb joint movement symmetry test;
[0113] The test content of the lower limb joint movement symmetry test includes: after the subject sets the wearable device at the knee joint, the subject performs lower limb joint movements of the damaged lower limb and the undamaged lower limb respectively in response to the fifth test instruction output by the user terminal, and the fifth test instruction includes: a leg lifting instruction and a hand-touching ankle joint instruction of the lifted leg;
[0114] The wearable device collects lower limb joint data of the subject in response to each fifth test instruction, and the lower limb joint data includes: joint movement amplitude, joint movement duration and joint movement speed.
[0115] Some subjects may have limited mobility, for example, hemiplegia after a stroke, or some knee damage; in this case, a lower limb joint movement symmetry test can be performed. The subjects are asked to place the wearable device on the damaged knee joint and the undamaged knee joint and perform the test.
[0116] Optionally, the collected knee joint motion data can be used to further infer the subject's hip joint motion data.
[0117] Optionally, the subject's physical strength score can be determined by testing at least one of the switching duration and switching speed of the instructions, and the difference between the movement range and movement speed of the joints (hip joint, ankle joint) between the subject's damaged lower limb and undamaged lower limb.
[0118] Conventional methods of testing the physical fitness of subjects, such as the six-minute walking test (6MWT), can also be applied to the diagnosis, prognosis and outcome evaluation of chronic diseases, but the simple 6MWT test is easily affected by the test environment, resulting in difficulty in collecting test data. This embodiment is based on a multi-drug optimization system, where the user terminal inputs test instructions, and the wearable device collects test data in real time, ensuring the accuracy and comprehensiveness of the test data, thereby further improving the accuracy of multi-drug regimen optimization.
[0119] In a feasible embodiment, during the lower limb joint movement symmetry test, the subject sets the wearable device at the knee joint, and the fifth test instruction continuously output by the user terminal includes: a leg lift instruction and a hand-touch ankle joint instruction of the lifted leg. Each instruction triggers the sensor to capture data within a specified time length until the next instruction is issued; after each test instruction is issued, the wearable device dynamically collects corresponding test data, such as the amplitude, speed and time of hip and knee joint movement, and marks the corresponding timestamp for the test data under each instruction, and then determines the difference in bilateral limb parameters of the subject through the collected data, thereby further determining the subject's physical strength score.
[0120] In this embodiment, each test item of the structured functional test can be used to evaluate the arch gap and / or hip flexion performance, and is suitable for elderly people with normal aging and neurological disorders. It can evaluate the fall risk of the elderly, track sports items and exercise intensity, and evaluate motor function and health status.
[0121] In a feasible implementation manner, the test data includes: test data before taking the medicine and test data after taking the medicine. Step S20, based on the test data, the step of determining the drug efficacy index of the subject to the taken medicine includes:
[0122] Step S21, scoring the pre-medication test data and the post-medication test data according to a preset physical strength scoring standard, to obtain the pre-medication physical strength score and the post-medication physical strength score of the subject;
[0123] Step S22, determining the physical strength difference between the physical strength score before taking the medicine and the physical strength score after taking the medicine;
[0124] According to the preset physical strength scoring standard, the test data before and after taking the medicine are scored respectively, and the score difference (physical strength score difference) is calculated; and the physical strength score difference is further compared with the preset physical strength standard value. If the physical strength score difference is greater than the physical strength standard value, it is determined that the subject is sensitive to the medicine taken; if the physical strength score difference is less than or equal to the physical strength standard value, it is determined that the subject is resistant to the medicine taken.
[0125] Exemplarily, reference values for structured functional tests are shown in Table 1; for different daily activity categories, i.e., indoor, outdoor, and social activities, reference values for different structured functional test items after the subject takes the medicine and reaches the preset efficacy level are given. Combining the following reference values with the preset physical strength scoring standard, the test data before and after the subject takes the medicine can be scored, and the physical strength difference between the physical strength score before and after taking the medicine can be calculated.
[0126] Table 1:
[0127]
[0128] Step S23, determining the drug efficacy index corresponding to each of the drugs taken by the subject according to the physical strength score difference and the dosage corresponding to each of the drugs taken by the subject.
[0129] The ratio between the difference in physical strength and the corresponding dose of each type of drug in the drugs taken is determined as the corresponding pharmacodynamic index of each type of drug in the drugs taken by the subject.
[0130] Furthermore, the embodiment of the present application also provides a multi-drug regimen optimization system, which includes:
[0131] Wearable devices, user terminals and control terminals that are communicatively connected to each other;
[0132] Wearable devices to collect test data from structured functional tests of subjects before and after multiple medication administrations;
[0133] A user terminal, used to send preset test instructions and preset brain stimulation signals to the subject;
[0134] The control terminal is used to obtain test data of structured functional tests of subjects before and after multiple medications collected by the wearable device, wherein the structured functional test is used to reflect the subject's goal-oriented motor function; based on the test data, the pharmacodynamic index of the subject to the medication taken is determined, wherein the pharmacodynamic index is used to indicate the subject's sensitivity and / or tolerance to the medication taken; the dose and pharmacodynamic index corresponding to each medication taken by the subject are used as input data, and are input into a preset multi-drug regimen optimization model for prediction, so as to obtain a medication regimen for the subject to achieve a preset efficacy level, wherein the medication regimen includes: the dose, medication interval and medication frequency corresponding to each medication taken by the subject at a single time.
[0135] Optionally, the user terminal may be an APP in a smart terminal, which may display a preset user interface to the subject, wherein the optimized medication regimen is displayed in the user interface, wherein the medication regimen includes medication dosage, medication interval, and medication frequency for different types of daily activities (e.g., indoor activities, outdoor activities, social activities, etc.). The user interface may also include a limb function assessment report for displaying the test results of each test item of the structured functional test.
[0136] For example, refer to Figure 3 The user interface displayed by the user terminal to the subject includes medication plans for indoor activities, outdoor activities and social activities; the drugs taken by the subject are mixed drugs with different drug strengths prepared according to the optimized medication plan, and different colors are used to distinguish the drug strengths of each mixed drug. Users can know how to take the medicine by viewing the medication plan that is the same as their daily activity type today, which improves the convenience of medication for patients taking multiple drugs.
[0137] In one feasible implementation, the wearable device includes: a posture sensor and an elastic member;
[0138] The elastic member is used to fix the wearable device to the joint of the subject;
[0139] A pocket structure is provided in the elastic member for fixing the posture sensor.
[0140] Since the muscle groups of the limbs are prone to destroying the stability of the sensor, which in turn leads to inaccurate data collected by the sensor; therefore, this embodiment provides a wearable device, including an elastic member, which is designed according to the characteristics of human muscle tissue (such as shape, elasticity, and movement characteristics) and is used to fix the wearable device to the joints of the subject and prevent the subject from destroying the stability of the posture sensor during movement, wherein the joints include: elbow joints, knee joints, etc. The elastic member is also provided with a pocket structure for fixing the posture sensor.
[0141] The posture sensor may include: a gyroscope and an accelerometer, which have noise filtering and drift correction functions. The posture sensor may be operated by an integrated circuit board, which calculates the angular velocity of the flexion of the hip joint, knee joint or ankle joint and other data at a sampling frequency greater than 50 Hz. The user terminal may include a touch display screen for receiving the subject's input of basic body data, such as limb length, etc., and continuously updating and displaying the data collected during the test.
[0142] For example, refer to Figure 6 The wearable device includes a posture sensor 10 and an elastic member 20, and a pocket structure 21 is provided on the elastic member 20 for fixing the posture sensor 10; the elastic member 20 can be a silicone strap, and a Velcro is also provided on it to facilitate the user to wear it on the limbs.
[0143] Optionally, users can remotely perform structured functional tests and multi-drug regimen optimization on subjects through the multi-drug regimen optimization system, and dynamically modify relevant parameters of the structured functional tests to facilitate use by subjects in remote areas.
[0144] For example, refer to Figure 7 This is a schematic diagram of the multi-drug regimen optimization system. Users can wear wearable devices and use mobile phone APP (i.e. user terminal) to conduct limb function assessment (i.e. structured functional test) and rehabilitation training in institutions (including hospitals, rehabilitation institutions and nursing homes) or at home. Doctors and rehabilitation therapists can remotely guide and supervise patients through the various functions of the background management system (i.e. control terminal). The background management system stores relevant data in the database for easy access at any time. The posture sensor of the wearable device collects the patient's limb movement amplitude to assess the patient's limb function; the music playback is controlled according to the patient's limb movement amplitude, and the triple rehabilitation training of limb movement amplitude improvement, music therapy and aerobic exercise is organically combined to provide auxiliary basis for clinical diagnosis; according to the clinical treatment plan, it is used as an auxiliary rehabilitation training measure for surgery or drug treatment, and postoperative and out-of-hospital rehabilitation training is provided to improve the efficacy of surgery and drugs and the rehabilitation effect of patients.
[0145] The specific implementation methods of the multi-drug regimen optimization system of the present application are basically the same as the various embodiments of the multi-drug regimen optimization method described above, and will not be repeated here.
[0146] It should be noted that, in this article, the terms "include", "comprises" or any other variations thereof are intended to cover non-exclusive inclusion, so that a process, method, article or system including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or system. In the absence of further restrictions, an element defined by the sentence "comprises a ..." does not exclude the existence of other identical elements in the process, method, article or system including the element.
[0147] The above are only preferred embodiments of the present application, and are not intended to limit the patent scope of the present application. Any equivalent structure or equivalent process transformation made using the contents of the present application specification and drawings, or directly or indirectly applied in other related technical fields, are also included in the patent protection scope of the present application.
Claims
1. A multi-drug regimen optimization method, characterized in that: The multi-drug regimen optimization method is applied to a multi-drug regimen optimization system, the multi-drug regimen optimization system includes: a wearable device, and the method includes: Acquiring test data of a structured functional test of a subject before and after multiple medications collected by a wearable device, wherein the structured functional test is used to reflect the subject's goal-oriented motor function; Determining the drug efficacy index of the subject to the drug taken according to the test data, wherein the drug efficacy index is used to indicate the sensitivity and / or tolerance of the subject to the drug taken; According to the dosage and pharmacodynamic index corresponding to each drug taken by the subject, a medication regimen for the subject to achieve a preset efficacy level is determined, wherein the medication regimen includes: the dosage, medication interval and medication frequency corresponding to each drug taken by the subject at a single time.
2. The multi-drug regimen optimization method according to claim 1, characterized in that: The drug taken by the subject is a mixed drug prepared by dividing multiple drugs for single administration in a drug prescription and remixing them according to different doses.
3. The multi-drug regimen optimization method according to claim 2, characterized in that: The medicine taken by the subject is a mixed medicine prepared by cutting multiple medicines for single administration in a drug prescription into small portions by a laser cutting device and remixing them according to different doses, wherein the mixed medicine is a tablet or a capsule.
4. The multi-drug regimen optimization method according to claim 1, characterized in that: The multi-drug regimen optimization system includes: a user terminal, and the step of obtaining test data of a structured functional test of a subject before and after taking multiple medications collected by a wearable device includes: Control the user terminal to send a preset test instruction and a preset brain stimulation signal to the subject, so that the subject moves in response to the test instruction and the brain stimulation signal, and obtains the test data collected by the wearable device, wherein the brain stimulation signal is used to stimulate the subject's brain network.
5. The multi-drug regimen optimization method according to claim 1, characterized in that: The multi-drug regimen optimization system comprises: a user terminal, and the test items of the structured functional test comprise: an alternating speed walking test; The test content of the alternating speed walking test includes: after the subject sets the wearable device at the knee joint, the subject performs alternating speed walking in response to the first test instruction output by the user terminal, and the first test instruction includes: start walking instruction, fast walking instruction, slow walking instruction, turn instruction and stop walking instruction; The wearable device collects walking data of the subject in response to each of the first test instructions, and the walking data includes: walking step length, walking time and walking speed.
6. The multi-drug regimen optimization method according to claim 1, characterized in that: The multi-drug regimen optimization system includes: a user terminal, and the test items of the structured functional test include: an arm swing symmetry test; The test content of the arm swing symmetry test includes: after the subject sets the wearable device at the elbow joint, the subject performs an arm swing movement in response to a second test instruction output by the user terminal, and the second test instruction includes: a start swing instruction, a fast swing instruction, a slow swing instruction, and a stop swing instruction; The wearable device collects the swing data of the subject in response to each of the second test instructions, and the swing data includes: swing amplitude, swing duration and swing speed.
7. The multi-drug regimen optimization method according to claim 1, characterized in that: The multi-drug regimen optimization system comprises: a user terminal, and the test items of the structured functional test comprise: a cross-stepping test; The test content of the cross-stepping test includes: after the subject sets the wearable device at the knee joint, the subject performs a cross-stepping movement in response to a third test instruction output by the user terminal, and the third test instruction includes: an instruction for the first foot to move in a first horizontal direction, an instruction for the second foot to move in a second horizontal direction, and an instruction for the first foot to move in a third horizontal direction; The wearable device collects cross-stepping data of the subject in response to each of the third test instructions, and the cross-stepping data includes: cross-stepping step length, cross-stepping duration and cross-stepping speed.
8. The multi-drug regimen optimization method according to claim 1, characterized in that: The multi-drug regimen optimization system comprises: a user terminal, and the test items of the structured functional test comprise: a dual-task test of stepping in place; The test content of the dual-task stepping test includes: after the subject sets the wearable device at the knee joint, the subject performs single-task and dual-task stepping movements in response to the fourth test instruction output by the user terminal, and the fourth test instruction includes: a start stepping instruction and / or a question-and-answer instruction; The wearable device collects the in-place stepping data of the subject in response to each of the fourth test instructions, and the in-place stepping data includes: in-place stepping amplitude, in-place stepping duration and in-place stepping speed.
9. The multi-drug regimen optimization method according to claim 1, characterized in that: The multi-drug regimen optimization system comprises: a user terminal, and the test items of the structured functional test comprise: a lower limb joint movement symmetry test; The test content of the lower limb joint movement symmetry test includes: after the subject sets the wearable device at the knee joint, the subject performs lower limb joint movements of the damaged lower limb and the undamaged lower limb respectively in response to the fifth test instruction output by the user terminal, and the fifth test instruction includes: a leg lifting instruction and a hand-touching ankle joint instruction of the lifted leg; The wearable device collects lower limb joint data of the subject in response to each of the fifth test instructions, and the lower limb joint data includes: joint movement amplitude, joint movement duration and joint movement speed.
10. The multi-drug regimen optimization method according to claim 1, characterized in that: The test data includes: test data before taking the medicine and test data after taking the medicine. The step of determining the drug efficacy index of the subject to the taken medicine according to the test data includes: According to a preset physical strength scoring standard, the pre-drug test data and the post-drug test data are scored respectively to obtain the pre-drug physical strength score and the post-drug physical strength score of the subject; Determining the physical strength score difference between the physical strength score before taking the medication and the physical strength score after taking the medication; The drug efficacy index corresponding to each of the drugs taken by the subject is determined according to the physical strength score difference and the dosage corresponding to each of the drugs taken by the subject.
11. The multi-drug regimen optimization method according to claim 1, characterized in that: The step of determining the medication regimen for the subject to achieve a preset efficacy level according to the dosage and pharmacodynamic index corresponding to each of the drugs taken by the subject comprises: The dosage and pharmacodynamic index corresponding to each drug taken by the subject are used as input data, and are input into a preset multi-drug regimen optimization model for prediction to obtain the medication regimen, wherein the multi-drug regimen optimization model is used to predict the therapeutic effect of each drug on the user and the brain damage area corresponding to the therapeutic effect based on the different dosages of each drug.
12. The multi-drug regimen optimization method according to claim 11, characterized in that: The input data also includes: clinical diagnosis data, brain injury degree data and daily activity plan data of the subject.
13. A multi-drug regimen optimization system, characterized in that: The multi-drug regimen optimization system includes: a wearable device, a user terminal and a control terminal that are communicatively connected to each other; The wearable device is used to collect test data of structured functional tests of subjects before and after multiple medications; The user terminal is used to send a preset test instruction and a preset brain stimulation signal to the subject; The control terminal is used to obtain test data of a structured functional test of a subject before and after taking multiple medications collected by a wearable device, wherein the structured functional test is used to reflect the subject's goal-oriented motor function; determine the subject's pharmacodynamic index to the medication taken based on the test data, wherein the pharmacodynamic index is used to indicate the subject's sensitivity and / or tolerance to the medication taken; determine a medication regimen for the subject to achieve a preset efficacy level based on the dose and pharmacodynamic index corresponding to each medication taken by the subject, wherein the medication regimen includes: the dose, medication interval, and medication frequency corresponding to each medication taken by the subject at a single time.
14. The multi-drug regimen optimization system according to claim 13, characterized in that: The wearable device comprises: a posture sensor and an elastic member; The elastic member is used to fix the wearable device to the joint of the subject; The elastic member is provided with a pocket structure for fixing the posture sensor.
